Ethnicity study and non-selective screening for haemoglobinopathies in the antenatal population of central Manchester

M Kadkhodaei Elyaderani1, K I Cinkotai, K Hyde

  • 1University Department of Clinical Haematology, Manchester Royal Infirmary, UK.

Insights

Non-selective screening for haemoglobinopathies is recommended for pregnant individuals in Manchester. This ensures equitable access to care, particularly for ethnic minority groups with higher carrier frequencies.

Area of Science:

  • Medical Genetics
  • Public Health
  • Obstetrics

Background:

  • Haemoglobinopathies are inherited blood disorders.
  • Accurate ethnic data is crucial for targeted antenatal screening services.
  • Manchester has a diverse population requiring tailored healthcare approaches.

Purpose of the Study:

  • To determine the ethnic distribution of the antenatal population in central Manchester.
  • To assess the effectiveness of current haemoglobinopathy screening in reaching at-risk groups.
  • To inform service provision for antenatal haemoglobinopathy screening.

Main Methods:

  • Analysis of ethnic data from 6718 antenatal patients over 7 months.
  • Screening of 1144 patients for haemoglobinopathies over 1 month.
  • Calculation of carrier frequencies across different ethnic groups.

Main Results:

  • The antenatal population comprised 62.3% White, 13.2% Asian, 7.9% Black, and 3.8% other ethnic groups.
  • Overall haemoglobinopathy incidence was 2.62% in the screened subset.
  • Highest carrier frequencies were observed in the Black (18.2%) and 'no information' (5.6%) groups.

Conclusions:

  • A significant proportion of the antenatal population belongs to ethnic minority groups.
  • The high incidence of haemoglobinopathies in certain ethnic groups and the 'no information' category supports universal screening.
  • Non-selective screening is recommended for all pregnant individuals in central Manchester to ensure equitable care.